909089-13-0
909089-13-0
Chemical Structure
SKL2001
- CAS No.: 909089-13-0
- Formula:C14H14N4O3
- Molecular Weight:286.29
IUPAC Name: N-(3-(1H-imidazol-1-yl)propyl)-5-(furan-2-yl)isoxazole-3-carboxamide
InChIKey: PQXINDBPUDNMPE-UHFFFAOYSA-N
SMILES: O=C(C1=NOC(C2=CC=CO2)=C1)NCCCN3C=CN=C3
Biological Activity: SKL2001 is an agonist of the Wnt/β-catenin pathway, with anti-cancer activity. SKL2001 stabilizes intracellular β-catenin via disruption of the Axin/β-catenin interaction[1].
| Cat. No. | Nom du produit | Pureté | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
SKL2001 | 99.70% | SKL2001 is an agonist of the Wnt/β-catenin pathway, with anti-cancer activity. SKL2001 stabilizes intracellular β-catenin via disruption of the Axin/β-catenin interaction. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
SKL2001 (Standard) | ≥98% | SKL2001 (Standard) is the analytical standard of SKL2001 (HY-101085). This product is intended for research and analytical applications. SKL2001 is an agonist of the Wnt/β-catenin pathway, with anti-cancer activity. SKL2001 stabilizes intracellular β-catenin via disruption of the Axin/β-catenin interaction. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
SKL2001 (GMP) | SKL2001 (GMP) is SKL2001 (HY-101085) produced by using GMP guidelines. SKL2001 is an agonist of the Wnt/β-catenin pathway, with anti-cancer activity. SKL2001 stabilizes intracellular β-catenin via disruption of the Axin/β-catenin interaction. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
